Adherence to therapies in patients with type 2 diabetes.
about
Coadjuvants in the Diabetic Complications: Nutraceuticals and Drugs with Pleiotropic EffectsPoor medication adherence in type 2 diabetes: recognizing the scope of the problem and its key contributorsCurrent status of managing diabetes mellitus in KoreaCost-effectiveness of vildagliptin for people with type 2 diabetes mellitus in Brazil; findings and implications.The polypill approach - An innovative strategy to improve cardiovascular health in Europe.Long-term glycaemic response and tolerability of dapagliflozin versus a sulphonylurea as add-on therapy to metformin in patients with type 2 diabetes: 4-year data.Treatment patterns in patients with type 2 diabetes mellitus treated with glucagon-like peptide-1 receptor agonists: Higher adherence and persistence with dulaglutide compared with once-weekly exenatide and liraglutideCost of medication adherence and persistence in type 2 diabetes mellitus: a literature review.A 6-month follow-up study of the randomized controlled Ma-Pi macrobiotic dietary intervention (MADIAB trial) in type 2 diabetes.Clinical inertia in individualising care for diabetes: is there time to do more in type 2 diabetes?Recognition of and steps to mitigate anxiety and fear of pain in injectable diabetes treatmentDiabetes, diet-health behavior, and obesityA survey of patient preferences for oral antihyperglycemic therapy in patients with type 2 diabetes mellitus.Pill Burden in Patients With Type 2 Diabetes in Germany: Subanalysis From the Prospective, Noninterventional PROVIL StudyDosing of U-100 insulin and associated outcomes among Medicare enrollees with type 1 or type 2 diabetesDevelopment of an unsupportive social interaction scale for patients with diabetesSupporting self-management of type 2 diabetes: is there a role for the community pharmacist?Managing Diabetes Mellitus: A Survey of Attitudes and Practices Among Family PhysiciansPatients' and physicians' preferences for type 2 diabetes mellitus treatments in Spain and Portugal: a discrete choice experiment.Simultaneous Quantification of Antidiabetic Agents in Human Plasma by a UPLC-QToF-MS MethodPatients' perspective of disease and medication adherence for type 2 diabetes in an urban area in Bangladesh: a qualitative study.Sensitive and specific LC-ESI-MS/MS method for determination of ZYDPLA1, a novel long-acting dipeptidyl peptidase 4 inhibitor in rat plasma: An application for toxicokinetic study in rats.Use of V-Go® Insulin Delivery Device in Patients with Sub-optimally Controlled Diabetes Mellitus: A Retrospective Analysis from a Large Specialized Diabetes SystemPatients' with type 2 diabetes willingness to pay for insulin therapy and clinical outcomesThe Clinical and Economic Impact of the V-Go® Disposable Insulin Delivery Device for Insulin Delivery in Patients with Poorly Controlled Diabetes at High RiskAssessing the Effect of Personalized Diabetes Risk Assessments During Ophthalmologic Visits on Glycemic Control: A Randomized Clinical Trial.Attributes Influencing Insulin Pen Preference Among Caregivers and Patients With Diabetes Who Require Greater Than 20 Units of Mealtime Insulin.Adherence to GLP-1 receptor agonist therapy administered by once-daily or once-weekly injection in patients with type 2 diabetes in Germany.Persistence with Insulin Therapy in Patients with Type 2 Diabetes in France: An Insurance Claims Study.Development and Usability of REACH: A Tailored Theory-Based Text Messaging Intervention for Disadvantaged Adults With Type 2 Diabetes.Trends of antidiabetic drug use in adult type 2 diabetes in Korea in 2002-2013: Nationwide population-based cohort study.Understanding the physical, social, and emotional experiences of people with uncontrolled Type 2 diabetes: a qualitative study.A healthy diet with and without cereal grains and dairy products in patients with type 2 diabetes: study protocol for a random-order cross-over pilot study--Alimentation and Diabetes in Lanzarote--ADILAN.Patterns of User Engagement with Mobile- and Web-Delivered Self-Care Interventions for Adults with T2DM: A Review of the Literature.A multicentre demonstration project to evaluate the effectiveness and acceptability of the web-based Joint Asia Diabetes Evaluation (JADE) programme with or without nurse support in Chinese patients with Type 2 diabetesGlucagon-like Peptide-1 Receptor Agonist Treatment Attributes Important to Injection-Naïve Patients with Type 2 Diabetes Mellitus: A Multinational Preference Study.Glucagon-Like Peptide-1 Receptor Agonist Treatment Attributes Important to Injection-Experienced Patients with Type 2 Diabetes Mellitus: A Preference Study in Germany and the United Kingdom.Safety evaluation of trelagliptin in the treatment of Japanese type 2 diabetes mellitus patients.Patterns of glycaemic control in patients with type 2 diabetes mellitus initiating second-line therapy after metformin monotherapy: Retrospective data for 10 256 individuals from the United Kingdom and Germany.First novel once-weekly DPP-4 inhibitor, trelagliptin, for the treatment of type 2 diabetes mellitus.
P2860
Q26741423-88BBC145-F69C-4781-8553-5C02E1B0181CQ26741537-6DA1A53B-6160-4BC2-A78C-CDEE86950C73Q28069723-674522EF-4DB8-4A2F-AC6B-D22CC67AE686Q30234836-D9FEE02F-F782-4131-AB72-3B307F195E3DQ30398270-7A9B9A8F-9FE2-4685-ABD3-57D462FB5A8AQ30903369-C1AC7626-5AD8-4BDA-8B80-1B3325837FBDQ33835762-6A226047-CB9B-44FC-80B6-4825721C388AQ33884347-B6627981-71C0-4F22-BD46-7B2DED775327Q34678310-EA891983-309A-4CE2-A4B7-6DD461C82471Q34726295-81CF2D38-BF45-446A-9751-BFFF5C7A05C8Q35001542-0085191E-7D62-4CCA-91BD-F361E04CF852Q35179753-0534BE35-948E-4426-A7C6-A330CFF41A54Q35217938-C920D328-3028-43F7-AD25-24376B1F6F33Q35428960-917525D6-711B-487A-817E-2C6B2BC368CBQ35766301-45F8D9AD-3995-4EAD-ABA2-A12A42A53FF9Q35892904-DC201360-D542-4270-BA3B-B2F2CD6FCA03Q35923774-CAB5521F-6ED8-4209-A262-6679AFB41CDEQ36017120-9FB033D6-083F-4E78-8701-922F7A1C97CDQ36180785-00C6B3B0-6E37-46C0-9734-EB5AC5C57B33Q36216123-54D4ED37-87DC-4A6F-97CC-F49D477EBFC7Q36317655-C8619758-FDFE-4398-AC35-99D7C57D4A15Q36332490-43652439-395C-49C2-A034-450B0269B90CQ36360070-A145FF4F-E4F0-4BEE-B2C8-41F217E7D4A4Q36860522-F2E726D6-28B9-467B-AEB0-5EAB76F6969BQ37022927-26923B29-DA99-4EE2-95D7-42E943A3387EQ37045469-ACB280D9-0F42-4209-9F67-C1522A66C36CQ37054680-9595F33F-D10F-4381-85BB-376B37ADCC57Q37069371-488DF61F-66BB-4850-A790-EB0DDD2A5FA7Q37239307-B0D2354A-AAC0-40C4-9542-1643114DA3D9Q37277710-1335190F-6365-45CF-BA30-4903BDFE641FQ37327943-6F6DC4CA-BBF8-4FD4-851C-92D1F99E9DB1Q37413097-A97A0CD3-DFD1-43C7-9448-470C40E7A659Q37446284-1659F218-6805-4560-BBC0-BB1947B8A5BDQ37608501-1CC3EEDF-18AC-472A-AB0B-532F7CAFF4C3Q37663930-19B3590D-7E14-4A1A-9F2F-429E736A793DQ37737456-39F1CC33-7B82-4FC8-9120-28E73F69CA0BQ37737463-E853E522-AA38-44F9-9658-75CBD1E55A6EQ38614486-A45A2CE0-427C-4FFE-810D-45FE195B1ED3Q38620148-D68A8A17-A2FB-477A-8029-2B0AFEF8F18EQ38622203-7377B572-5601-482D-8867-4244D2F5F1CD
P2860
Adherence to therapies in patients with type 2 diabetes.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 30 August 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Adherence to therapies in patients with type 2 diabetes.
@en
Adherence to therapies in patients with type 2 diabetes.
@nl
type
label
Adherence to therapies in patients with type 2 diabetes.
@en
Adherence to therapies in patients with type 2 diabetes.
@nl
prefLabel
Adherence to therapies in patients with type 2 diabetes.
@en
Adherence to therapies in patients with type 2 diabetes.
@nl
P2093
P2860
P1433
P1476
Adherence to therapies in patients with type 2 diabetes
@en
P2093
Luis-Emilio García-Pérez
María Alvarez
Tatiana Dilla
P2860
P2888
P304
P356
10.1007/S13300-013-0034-Y
P577
2013-08-30T00:00:00Z